| ACEi | angiotensin-converting enzyme inhibitors |
| APA | aldosterone-producing adenomas |
| ARB | angiotensin2 receptor blockers |
| ARR | aldosterone-to-renin ratio |
| AVS | adrenal vein sampling |
| CCB | calcium channel blockers |
| CT | computed tomography |
| CV | cardiovascular |
| DALYs | disability-adjusted-life-years |
| DBP | diastolic blood pressure |
| DOC | desoxycorticosterone |
| DRC | direct renin concentration |
| GRA | Glucocorticoid remediable aldosteronism |
| MRA | mineralocorticoid receptor antagonists |
| MRI | magnetic resonance imaging |
| HTN | hypertension |
| PA | primary aldosteronism |
| PCR | polymerase chain reaction |
| PHA | pseudohypoaldosteronism |
| PGL | Paragangliomas |
| PPGL | pheochromocytoma and paraganglioma |
| PRA | plasma renin activity |
| RAS | renin-angiotensin system |
| RASb | renin-angiotensin system blockers |